Stocktoria
AdaptHealth Corp. AHCO
Nasdaq · XNAS · stock · Services-Home Health Care Services · website · IPO 2018-02-21
Chart by TradingView
5/9
Piotroski F — financial health
0.26
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $3.2B | $3.3B | $3.2B | $3.0B | $2.5B |
| Operating income | $90.9M | $263.7M | -$598.4M | $190.4M | $225.6M |
| Net income | -$70.8M | $90.4M | -$678.9M | $69.3M | $156.2M |
| Operating cash flow | $601.8M | $541.8M | $480.7M | $373.9M | $275.7M |
| Free cash flow | $219.4M | $235.8M | $143.2M | -$17.6M | $72.4M |
| Total assets | $4.3B | $4.5B | $4.5B | $5.2B | $5.3B |
| Total liabilities | $2.8B | $2.9B | $3.0B | $3.1B | $3.2B |
| Shareholders' equity | $1.5B | $1.6B | $1.5B | $2.2B | $2.1B |
| Ratios | |||||
| Operating margin | 2.8% | 8.1% | -18.7% | 6.4% | 9.2% |
| Net margin | -2.2% | 2.8% | -21.2% | 2.3% | 6.4% |
| FCF margin | 6.8% | 7.2% | 4.5% | -0.6% | 2.9% |
| Return on assets | -1.6% | 2.0% | -15.1% | 1.3% | 3.0% |
| Return on equity | -4.7% | 5.7% | -46.3% | 3.2% | 7.6% |
| Debt / equity | 1.14× | 1.26× | 1.46× | 1.00× | 1.07× |
| Current ratio | 1.02 | 1.33 | 1.21 | 1.28 | 1.34 |
| Revenue growth | -0.5% | 1.9% | 7.7% | 21.0% | 132.4% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 228,373 | $2.7M |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 0.26 (distress)
- Working capital / assets 0.004
- Retained earnings / assets -0.147
- EBIT / assets 0.021
- Equity / liabilities 0.544
Sector peers
GOOG · MSFT · META · BABA · DIS · HCA · all Services →
Source: SEC EDGAR filings · CIK 0001725255 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.